<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">347815</id>
  <title nil="true"/>
  <common-name>4-[4-chloro-3-(trifluoromethyl)phenyl]-1-[7-fluoro-4-(4-fluorophenyl)-1,2,3,4-tetrahydronaphthalen-1-yl]piperidin-4-ol</common-name>
  <description>4-[4-chloro-3-(trifluoromethyl)phenyl]-1-[7-fluoro-4-(4-fluorophenyl)-1,2,3,4-tetrahydronaphthalen-1-yl]piperidin-4-ol is a chemical compound with the formula C28H25ClF5NO. With an average molecular weight of 521.90 g/mol, 4-[4-chloro-3-(trifluoromethyl)phenyl]-1-[7-fluoro-4-(4-fluorophenyl)-1,2,3,4-tetrahydronaphthalen-1-yl]piperidin-4-ol is a heavy molecule.</description>
  <cas nil="true"/>
  <pubchem-id>3052028</pubchem-id>
  <chemical-formula>C28H25ClF5NO</chemical-formula>
  <weight>521.9</weight>
  <appearance nil="true"/>
  <melting-point nil="true"/>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility nil="true"/>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity nil="true"/>
  <use-source nil="true"/>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2026-08-31T11:38:24Z</created-at>
  <updated-at type="dateTime">2026-08-31T11:38:24Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id nil="true"/>
  <omim-id nil="true"/>
  <chebi-id nil="true"/>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id nil="true"/>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>C1CC(C2=C(C1C3=CC=C(C=C3)F)C=CC(=C2)F)N4CCC(CC4)(C5=CC(=C(C=C5)Cl)C(F)(F)F)O</moldb-smiles>
  <moldb-formula>C28H25ClF5NO</moldb-formula>
  <moldb-inchi>InChI=1S/C28H25ClF5NO/c29-25-9-3-18(15-24(25)28(32,33)34)27(36)11-13-35(14-12-27)26-10-8-21(17-1-4-19(30)5-2-17)22-7-6-20(31)16-23(22)26/h1-7,9,15-16,21,26,36H,8,10-14H2</moldb-inchi>
  <moldb-inchikey>HHWGOVJDOODUBN-UHFFFAOYSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal" nil="true"/>
  <moldb-mono-mass type="decimal">521.1544829</moldb-mono-mass>
  <origin nil="true"/>
  <state nil="true"/>
  <logp>6.9</logp>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id nil="true"/>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference nil="true"/>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM343708</chemdb-id>
  <dsstox-id nil="true"/>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id nil="true"/>
  <iupac>4-[4-chloro-3-(trifluoromethyl)phenyl]-1-[7-fluoro-4-(4-fluorophenyl)-1,2,3,4-tetrahydronaphthalen-1-yl]piperidin-4-ol</iupac>
  <moldb-polar-surface-area nil="true"/>
  <moldb-refractivity nil="true"/>
  <moldb-polarizability nil="true"/>
  <moldb-rotatable-bond-count nil="true"/>
  <moldb-acceptor-count nil="true"/>
  <moldb-donor-count nil="true"/>
  <moldb-pka-strongest-acidic nil="true"/>
  <moldb-pka-strongest-basic nil="true"/>
  <moldb-physiological-charge nil="true"/>
  <moldb-number-of-rings nil="true"/>
  <moldb-alogps-logp nil="true"/>
  <moldb-alogps-logs nil="true"/>
  <moldb-alogps-solubility nil="true"/>
  <kingdom>Organic compounds</kingdom>
  <superklass>Organoheterocyclic compounds</superklass>
  <klass>Piperidines</klass>
  <subklass>Phenylpiperidines</subklass>
  <paper-count type="integer" nil="true"/>
  <sync-id>CED0298152</sync-id>
  <structure-inchikey>HHWGOVJDOODUBN-UHFFFAOYSA-N</structure-inchikey>
  <structure-fingerprint>2000002000000000000000000000008000000000020200000008000000000000000002000000000080100000000000000008000000008000000008400000000000000000020402002000000010000000000000000000000000014000000000000000100000000000020100000000000000000000101049000008000000000000000000000028200000000000002000000000000001000000008004400000000000080001002000000000040000008100000000000000000000000000200000000000000000020010000000000000000200000000000010000000000002000040000000000000800000000000500000000000000000</structure-fingerprint>
  <structure-pattern-fingerprint>7014c2108532827081805b6181b8aa001a00140091072050803d20408a64e84c6c220854138000000104590840c0800004604225608d3225016e653984a04210c7190c811280141048901140127202028804c58051211f3740041c62402243058e28452f104c1220400c0480ddb4004c348680528501e1463118664002510a06505018084ef0820808060250c82c0288391d98124446de8a5023082060c0448c81d3109300b1cb208a044968017c77944ac80403a943084010904ab84cc00212a01012a644980333198086a0775542910c490010637070000d61028028010300903849341881c12011488c01591620860050043094c2842e9300910053800602</structure-pattern-fingerprint>
  <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAkAAAAKAAAAIABBgBgAAAAAgIGAGAAAAAC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</structure-pickle>
  <structure-indexed-at type="dateTime">2026-09-19T05:46:22Z</structure-indexed-at>
</compound>
